Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Currency in USD	2026
Operating Income	146.82 Million
Income Before Tax	151.66 Million
Income Tax Expense	30.30 Million
Net Income	121.36 Million
Eps	4.31
Epsdiluted	4.25
Weighted Average Shs Out	28.17 Million
Weighted Average Shs Out Dil	28.55 Million
Research And Development Expenses	N/A
Selling General And Administrative Expenses	48.10 Million
Depreciation And Amortization	6.71 Million
Interest Expense	N/A
Interest Income	N/A
Net Interest Income	4.99 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	201.64 Million
Ebitda	153.53 Million
Source	edgar
Ebit	146.82 Million

Medpace Holdings, Inc. Annual Reports (10-K)